HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.

AbstractUNLABELLED:
Host chromatin assembly can function as a barrier to viral infection. Epstein-Barr virus (EBV) establishes latent infection as chromatin-assembled episomes in which all but a few viral genes are transcriptionally silent. The factors that control chromatin assembly and guide transcription regulation during the establishment of latency are not well understood. Here, we demonstrate that the EBV tegument protein BNRF1 binds the histone H3.3 chaperone Daxx to modulate histone mobility and chromatin assembly on the EBV genome during the early stages of primary infection. We demonstrate that BNRF1 substitutes for the repressive cochaperone ATRX to form a ternary complex of BNRF1-Daxx-H3.3-H4, using coimmunoprecipitation and size-exclusion chromatography with highly purified components. FRAP (fluorescence recovery after photobleaching) assays were used to demonstrate that BNRF1 promotes global mobilization of cellular histone H3.3. Mutation of putative nucleotide binding motifs on BNRF1 attenuates the displacement of ATRX from Daxx. We also show by immunofluorescence combined with fluorescence in situ hybridization that BNRF1 is important for the dissociation of ATRX and Daxx from nuclear bodies during de novo infection of primary B lymphocytes. Virion-delivered BNRF1 suppresses Daxx-ATRX-mediated H3.3 loading on viral chromatin as measured by chromatin immunoprecipitation assays and enhances viral gene expression during early infection. We propose that EBV tegument protein BNRF1 replaces ATRX to reprogram Daxx-mediated H3.3 loading, in turn generating chromatin suitable for latent gene expression.
IMPORTANCE:
Epstein-Barr Virus (EBV) is a human herpesvirus that efficiently establishes latent infection in primary B lymphocytes. Cellular chromatin assembly plays an important role in regulating the establishment of EBV latency. We show that the EBV tegument protein BNRF1 functions to regulate chromatin assembly on the viral genome during early infection. BNRF1 alters the host cellular chromatin assembly to prevent antiviral repressive chromatin and establish chromatin structure permissive for viral gene expression and the establishment of latent infection.
AuthorsKevin Tsai, Lilian Chan, Rebecca Gibeault, Kristen Conn, Jayaraju Dheekollu, John Domsic, Ronen Marmorstein, Luis M Schang, Paul M Lieberman
JournalJournal of virology (J Virol) Vol. 88 Issue 24 Pg. 14350-63 (Dec 2014) ISSN: 1098-5514 [Electronic] United States
PMID25275136 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014, American Society for Microbiology. All Rights Reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Co-Repressor Proteins
  • DAXX protein, human
  • Molecular Chaperones
  • Mutant Proteins
  • Nuclear Proteins
  • P140 protein, Epstein-barr virus
  • Viral Envelope Proteins
  • DNA Helicases
  • ATRX protein, human
  • X-linked Nuclear Protein
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • B-Lymphocytes (virology)
  • Binding Sites
  • Cells, Cultured
  • Chromatography, Gel
  • Co-Repressor Proteins
  • DNA Helicases (antagonists & inhibitors)
  • Fluorescence Recovery After Photobleaching
  • Fluorescent Antibody Technique
  • Herpesvirus 4, Human (physiology)
  • Host-Pathogen Interactions
  • Humans
  • Immunoprecipitation
  • In Situ Hybridization, Fluorescence
  • Molecular Chaperones
  • Mutagenesis, Site-Directed
  • Mutant Proteins (genetics, metabolism)
  • Nuclear Proteins (antagonists & inhibitors, metabolism)
  • Protein Binding
  • Protein Multimerization
  • Viral Envelope Proteins (metabolism)
  • Virus Latency
  • X-linked Nuclear Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: